Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Oct 2025 for Nirvana Life Sciences In., €44k.
Filing timeline
BuySaleSheldon Inwentash
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
Sheldon Inwentash: trading record in brief
This profile gathers the share dealings of Sheldon Inwentash in Nirvana Life Sciences In. We count 8 filings; the first trade dates from 17 March 2022 and the latest from 4 July 2025.
The open-market record is one-sided, with 3 purchases worth €76k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2025, the count stands at 3 purchases and no sales.
The median purchase comes to €18k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
Most recently, on 11 October 2025, the filings show an open-market purchase worth €44k in Nirvana Life Sciences In. Filings reach the SEDI feed a median of 51 days after the trade. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to Sheldon Inwentash
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
1,416,468 shares@ CA$0.0558.3% of flowCommon SharesTSXSEDI:4591330
Canonical exit: 2 Oct 2025 (T+90)
439,567 shares@ CA$0.0518.1% of flowCommon SharesTSXSEDI:4591318
Canonical exit: 2 Oct 2025 (T+90)
574,322 shares@ CA$0.0523.6% of flowCommon SharesTSXSEDI:4591316
Canonical exit: 2 Oct 2025 (T+90)
Common SharesTSXSEDI:4591317
1,500,000 sharesCommon SharesTSXSEDI:4533069
3,575,000 sharesCommon SharesTSXSEDI:4533075
150,000 sharesCommon SharesTSXSEDI:4533071
357,500 sharesCommon SharesTSXSEDI:4533076
8 of 8 declarations
